The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study

🔗 Access full article via Annals of Oncology

To assess the association between neoadjuvant therapy and overall survival (OS) in patients with left-sided resectable pancreatic cancer (RPC) compared to upfront surgery.